Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan ®) in the management of squamous cell carcinoma of the head and neck: Experience with 35 patients

European Archives of Oto-Rhino-Laryngology

Volumn 266, Issue 12, 2009, Pages 1937-1944

  Lorenz, Kai Johannes ^a   Maier, Heinz ^a  

^a BUNDESWEHRKRANKENHAUS ULM   (Germany)

Author keywords

Foscan; Head and neck tumours; MTHPC; Photodynamic therapy; Squamous cell carcinoma

Indexed keywords

TEMOPORFIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MESOPORPHYRINS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70350567170     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-009-0947-2     Document Type: Article

References (32)

1. CS Betz A Leunig 2004 Möglichkeiten und Grenzen der Fluoreszenzdiagnostik und photodynamischen Therapie. Teil II : Photodynamische Therapie HNO 52 175 192 10.1007/s00106-003-1029-1 10.1007/s00106-003-1029-1 1:STN:280:DC%2BD2c7ls1Sntw%3D%3D 15049331 (Pubitemid 38270452)
2. MA Biel 1994 Photodynamic therapy and the treatment of neoplastic diseases of the larynx Laryngoscope 104 399 403 10.1288/00005537-199404000-00001 10.1288/00005537-199404000-00001 1:STN:280:DyaK2c3hslChsA%3D%3D 8164476
3. MA Biel 1996 Photodynamic therapy and the treatment of head and neck cancers J Clin Laser Med Surg 14 239 244 1:STN:280:DyaK1c3nsFWgtA%3D%3D 9612189
4. MA Biel 1996 Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas Arch Otolaryngol Head Neck Surg 122 1261 1265 1:STN:280:DyaK2s%2Fmt1eitw%3D%3D 8906063
5. SA Blant TM Glanzmann JP Ballini G Wagnieres H Van den Bergh P Monnier 2002 Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study Br J Cancer 87 1470 1478 10.1038/sj.bjc.6600651 10.1038/sj.bjc.6600651 1:CAS:528:DC%2BD38XovFKrsL0%3D 12454779 (Pubitemid 36044325)
6. D Braichotte JF Savary T Glanzmann, et al. 1995 Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths Int J Cancer 63 198 204 10.1002/ijc.2910630209 10.1002/ijc.2910630209 1:CAS:528:DyaK2MXpsl2kt74%3D 7591204
7. AL Carvalho JV Salvajoli LP Kowalski 2000 A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas Eur Arch Otorhinolaryngol 257 164 167 10.1007/s004050050216 10.1007/s004050050216 1:STN:280:DC%2BD3cvmvFWgug%3D%3D 10839492
8. MP Copper IB Tan H Oppelaar MC Ruevekamp FA Stewart 2003 Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck Arch Otolaryngol Head Neck Surg 129 709 711 10.1001/archotol.129.7.709 10.1001/archotol.129.7.709 12874068 (Pubitemid 36858954)
9. AK D'Cruz MH Robinson MA Biel 2004 mTHPC-mediated photodynamic therapy in patients with advanced incurable head and neck cancer: a multicenter study of 128 patients Head Neck 26 232 240 10.1002/hed.10372 10.1002/hed.10372 14999798 (Pubitemid 38292733)
10. MG Dilkes G Alusi BJ Djaezeri 1999 The treatment of head and neck cancer with photodynamic therapy: clinical experience Rev Contemp Pharmacother 10 47 57 1:CAS:528:DyaK1MXjtVOgsbs%3D
11. CS Foote FC Shook RB Abakerli 1984 Characterization of singlet oxygen Methods Enzymol 105 36 47 10.1016/S0076-6879(84)05006-0 10.1016/S0076-6879(84) 05006-0 1:CAS:528:DyaL2cXltVKrtLY%3D 6727677
12. A Forastiere W Koch A Trotti D Sidransky 2001 Head and neck cancer N Engl J Med 345 1890 1900 10.1056/NEJMra001375 10.1056/NEJMra001375 1:STN:280:DC%2BD38%2FlvFektA%3D%3D 11756581
13. A Forastiere B Metch DE Schuller 1992 Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck. A Southwest Oncology Group study J Clin Oncol 10 1245 1251 1:STN:280:DyaK38zktFWguw%3D%3D 1634913
14. E Galante G Gallus F Chiesa A Bono I Bettoni R Molinari 1982 Growth rate of head and neck tumors Eur J Cancer Clin Oncol 18 707 712 10.1016/0277-5379(82) 90067-0 10.1016/0277-5379(82)90067-0 1:STN:280:DyaL3s7gsFantQ%3D%3D 6891321 (Pubitemid 12033222)
15. C Gedlicka M Formaneck E Selzer M Burian J Kornfehl W Fiebiger M Cartellieri B Marks GV Kornek 2002 Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck Oncology 63 145 150 10.1159/000063809 10.1159/000063809 1:CAS:528:DC%2BD38XntFegtL4%3D 12239449
16. C Glanzmann KW Gratz 1995 Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors Radiother Oncol 36 94 100 10.1016/0167-8140(95)01583-3 10.1016/0167-8140(95)01583-3 1:STN:280: DyaK28%2FovFyrtw%3D%3D 7501817
17. WE Grant C Hopper PM Speight AJ MacRobert SG Bown 1993 Photodynamic therapy of malignant and premalignant lesions in patients with field cancerization of the oral cavity J Laryngol Otol 107 1140 1145 10.1017/S0022215100125496 10.1017/S0022215100125496 1:STN:280: DyaK2c7hsl2ktA%3D%3D 8289004
18. C Hopper C Niziolb M Sidhub 2004 The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK Oral Oncol 40 372 382 10.1016/j.oraloncology.2003.09.003 10.1016/j.oraloncology.2003.09.003 1:STN:280:DC%2BD2c%2FotFaksA%3D%3D 14969816 (Pubitemid 38221384)
19. C Hopper A Kübler H Lewis B Tan G Putnam 2004 mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma Int J Cancer 111 138 146 10.1002/ijc.20209 10.1002/ijc.20209 1:CAS:528:DC%2BD2cXlsFWrtbg%3D 15185355 (Pubitemid 38859295)
20. F Heimlich A Dietz V Daniel H Maier 1999 Einflu tumorchirurgischer Eingriffe im Kopf-Hals-Bereich auf das Immunsystem HNO 47 885 892 10.1007/s001060050529 10.1007/s001060050529 1:STN:280:DC%2BD3c%2FitVWjtA%3D%3D 10550372 (Pubitemid 29512890)
21. S Kramer VA Marcial TF Pajak CJ MacLean LW Davis 1986 Prognostic factors for loco/regional control and metastasis and the impact on survival Int J Radiat Oncol Biol Phys 12 573 578 1:STN:280:DyaL287psFCitw%3D%3D 3516952
22. AC Kübler M Scheer JE Zoller 2001 Photodynamic therapy of head and neck cancer Onkologie 24 230 237 10.1159/000055085 10.1159/000055085 11455215 (Pubitemid 32664552)
23. A Kübler, et al. 2005 Eine Kosten-Effektivitätsanalyse der photodynamischen Therapie mit Foscan im Vergleich zur palliativen Chemotherapie bei Patienten mit fortgeschrittenen Kopf-Halstumoren in Deutschland Laryngorhinootologie 84 1 8 10.1055/s-2005-861048 10.1055/s-2005-861048 (Pubitemid 41545861)
24. H Maier V Daniel F Heimlich C Frank G Opelz 1995 Zelluäre Immundefekte durch postoperative Bestrahlung bei Patienten mit Plattenepithelkarzinomen des oberen Aerodigestivtraktes HNO 43 364 370 1:STN:280:DyaK2MzntVShtQ%3D%3D 7642397
25. P Moosmann F Egli RA Stahel L Jost 2003 Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck Onkologie 26 568 572 10.1159/000074153 10.1159/000074153 1:CAS:528:DC%2BD2cXhtFSgsw%3D%3D 14709932 (Pubitemid 38056744)
26. J Nollert V Rudat V Daniel H Maier A Dietz 1999 Einflu der primären Radiochemotherapie auf zelluläre und subzelluläre immunologische Parameter HNO 47 1058 1062 10.1007/s001060050491 10.1007/s001060050491 1:STN:280:DC%2BD3c7hvFKkuw%3D%3D 10654183 (Pubitemid 30017083)
27. Steel GG (1997) The growth rate of tumours. In: Steel G (ed) Basic clinical radiobiology, 2nd edn. Arnold, London, pp 9-13
28. The European Agency for the Evaluation of Medicinal Products (2001) Foscan: Summary of product characteristics
29. JB Vermorken R Mesia F Rivera E Remenar A Kawecki S Rottey J Erfan D Zabolotnyy H Kienzer D Cupissol F Peyrade M Benasso I Vynnychenko D De Raucourt C Bokemeyer A Schueler N Amellal R Hitt 2008 Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 11 1116 1127 10.1056/ NEJMoa0802656 10.1056/NEJMoa0802656
30. E Weymuller R Alsarraf B Yueh F Deleyiannis M Coltrera 2001 Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R) Arch Otolaryngol Head Neck Surg 127 5 489 493 11346422
31. Wheeler RH (1990) Chemotherapy of patients with recurrent head and neck cancer. In: Jacobs C (ed) Carcinomas of the head and neck: evaluation and management. Kluwer, Boston, pp 171-193
32. SJ Wong M Machtay Y Li 2006 Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 24 2653 2658 10.1200/JCO.2005.05.3850 10.1200/JCO.2005.05. 3850 16763279 (Pubitemid 46622086)